icd-10 code for chlamydia screening

What is the diagnosis for chlamydia?

• Small amounts of clear or cloudy discharge from the tip of your penis
• Painful urination
• Burning and itching around the opening of your penis
• Pain and swelling around your testicles

What ICD 10 cm code(s) are reported?

What is the correct ICD-10-CM code to report the External Cause? Your Answer: V80.010S The External cause code is used for each encounter for which the injury or condition is being treated.

What is the CPT code for chlamydia?

• All pregnant women in the first trimester; and
• All sexually active women aged 24 years and younger; and
• Women 25 years and older with any of the following risk factors for C. trachomatis infection: Having had C. ...

What is the ICD 10 diagnosis code for?

The ICD-10-CM is a catalog of diagnosis codes used by medical professionals for medical coding and reporting in health care settings. The Centers for Medicare and Medicaid Services (CMS) maintain the catalog in the U.S. releasing yearly updates.

What age is chlamydia screening?

Chlamydia screening among young women under the age of 26 is a measure that has been adopted by the National Committee for Quality Assurance (NCQA) for inclusion in the Health Plan Employer Data and Information Set (HEDIS).

Is there a gold standard for chlamydia?

This is because for many infectious diseases including chlamydia, a true gold standard simply does not exist and, as a result, estimation of test performance parameters in the absence of a gold standard is a difficult and challenging task.

Is chlamydia a sexually transmitted disease?

Kamel et al (2013) stated that C. trachomatis infection is a worldwide-distributed sexually transmitted infection that may lead to infertility.

Can C. trachomatis cause infertility?

Most C. trachomatis infections cause no symptoms. Left untreated, C. trachomatis infection can lead to complications such as pelvic inflammatory disease in the female, which has emerged as a major cause of tubal factor infertility and ectopic pregnancy in women of childbearing age.

Is chlamydial screening recommended?

The USPSTF made no recommendation for or against routine screening of asymptomatic, low-risk pregnant women aged 25 years and older for chlamydial infection. The USPSTF found fair evidence that the benefits of screening low-risk pregnant women are small and may not justify the possible harms.

Does chlamydia trachomatis cause cervical cancer?

Zhu and colleagues (2016) stated that as whether chlamydia trachomatis infection increases the risk of cervical cancer is controversial in the literature, these investigators performed a meta-analysis. Based on a comprehensive search of publications in the Medline, Cochrane, and Embase databases, these researchers identified and extracted data from all relevant articles examining C. trachomatis infection and the risk of cervical cancer. The quality of each included study was assessed according to the 9-star Newcastle-Ottawa scale. The strength of association between the C. trachomatis and risk of cervical cancer was estimated by odds ratio (OR) and 95 % CIs. A total of 22 studies with 4,291 cervical cancer cases and 7,628 controls were identified. Overall, C. trachomatis was significantly linked to increased cervical cancer risk in prospective studies (OR = 2.21, 95 % CI: 1.88 to 2.61, p < 0.001), as well as in retrospective studies (OR = 2.19, 95 % CI: 1.74 to 2.74, p < 0.001). Additionally, with a multi-variate logistic regression analysis adjusted for HPV and age, C. trachomatis infection was identified as an independent predictor of cervical cancer in 11 studies (OR = 1.76, 95 % CI: 1.03 to 3.01, p = 0.04). Co-infection of human papilloma virus (HPV) and C. trachomatis has a higher risk of cervical cancer (OR = 4.03, 95 % CI: 3.15 to 5.16, p < 0.001). A subgroup analysis based on histological type indicated an elevated risk for both squamous cell carcinoma (OR = 2.21, 95 % CI: 2.00 to 2.45, p < 0.001), and adenocarcinoma (OR = 1.61, 95 % CI: 1.21 to 2.15, p = 0.001), in associated with C. trachomatis. Subgroup analysis by where C. trachomatis infection was detected showed a significantly higher risk of cervical cancer associated with C. trachomatis infection detected in serum (OR = 2.20, 95 % CI: 2.01 to 2.42, p < 0.001), cervical tissue blocks (OR = 2.88, 95 % CI: 1.21 to 6.83, p = 0.02), and cervical secretion (OR = 2.71, 95 % CI: 1.41 to 5.20, p = 0.003), especially in serum with no obvious heterogeneity. The authors concluded that these novel data demonstrated that individuals infected with C. trachomatis have a higher risk of cervical cancer. Thus, it is necessary to expand C. trachomatis infection screening and treat women with C. trachomatis promptly, particularly those with HPV infections. They stated that this approach will not only protect against pelvic inflammatory disease (PID) and infertility, but may also prevent cervical cancer. Moreover, these researchers stated that the underlying interaction between C. trachomatis and cervical cancer risk needs to be confirmed in longitudinal studies. Thus, the findings of this study called for further investigation in more prospective studies to provide more definitive evidence concerning the role of this pathogen as a promoter of HPV-mediated cervical carcinogenesis.